In these HLA-A2:01+ melanoma cell lines, Melan-A peptide presentation induced a small but significant increase in the fraction of activated (IFNγ+CD107+) allogeneic HLA-A02 matched or autologous CD8+ T cells (Fig. 4B). The gene discussed is MLANA; the disease is melanoma.